I-cyclobenzaprine hydrochloride: yenzelwe ini nokuthi ungayithatha kanjani

-Delile

• Isetshenziswa kanjani
• Isebenza kanjani
• Ingabe i-cyclobenzaprine hydrochloride ikwenza uzele?
• Imiphumela emibi engaba khona
• Ngubani ongafanele asebenzise

I-cyclobenzaprine hydrochloride ikhonjisiwe ekwelashweni kwemisipha ehambisana nobuhlungu obukhulu nemvelaphi yemisipha, njengobuhlungu beqolo, i-torticollis, i-fibromyalgia, i-scapular-humeral periarthritis kanye ne-cervicobraquialgias. Ngaphezu kwalokho, ingasetshenziswa futhi njengesihlanganisi se-physiotherapy, ukuthola impumuzo yezimpawu.

Le nto esebenzayo iyatholakala ngokujwayelekile noma ngaphansi kwamagama okuhweba iMiosan, Benziflex, Mirtax neMusculare futhi ingathengwa ezikhemisi.

Hlangana nezinye izinto zokuphumula zemisipha ezingabekwa udokotela wakho.

Isetshenziswa kanjani

I-cyclobenzaprine hydrochloride itholakala kumaphilisi ama-5 mg kanye no-10 mg. Umthamo onconywayo ungama-20 kuye kuma-40 mg ekuphathweni okubili kuya kwemine okuhlukaniswe usuku lonke, ngomlomo. Umthamo omkhulu ka-60 mg ngosuku akufanele weqiwe.

Isebenza kanjani

ICyclobenzaprine hydrochloride iyi-relaxant yemisipha ecindezela ukuqhuma kwemisipha ngaphandle kokuphazamisa ukusebenza kwemisipha. Lo muthi uqala ukusebenza cishe ngehora elingu-1 ngemuva kokuphathwa.

Ingabe i-cyclobenzaprine hydrochloride ikwenza uzele?

Omunye wemiphumela emibi kakhulu engadalwa yilomuthi ukozela, ngakho-ke kungenzeka ukuthi abanye abantu abelashwa bazizwe bezele.

Imiphumela emibi engaba khona

Izenzo ezimbi kakhulu ezivame ukwenzeka ngesikhathi sokwelashwa nge-cyclobenzaprine hydrochloride ukozela, umlomo owomile, isiyezi, ukukhathala, ubuthakathaka, i-asthenia, isicanucanu, ukuqunjelwa, ukugayeka komgogodla, ukunambitheka okungathandeki, ukungaboni kahle, ikhanda elibuhlungu, uvalo nokudideka.

Ngubani ongafanele asebenzise

I-cyclobenzaprine hydrochloride akufanele isetshenziswe kubantu abazwela ngokweqile entweni esebenzayo noma kunoma iyiphi enye ingxenye yefomula yomkhiqizo, ezigulini ezine-glaucoma noma ukugcinwa komchamo, abathatha i-monoaminoxidase inhibitors, abasesigabeni esibucayi se-post-infarction se i-myocardium noma abahlushwa i-arrhythmia yenhliziyo, ukuvinjelwa, ukuguqulwa kokuziphatha, ukuhluleka kwenhliziyo yokuqina noma i-hyperthyroidism.

Ngaphezu kwalokho, akufanele futhi isetshenziswe ngabesifazane abakhulelwe noma omama abahlengikazi, ngaphandle kwalapho kunconywa udokotela.